24th ANNUAL BIKE MS: TOUR DE VINE RAISES OVER $270,000
More than 400 cyclists, volunteers and their families participate in
Bike MS: Tour de Vine to raise awareness and funds for Multiple Sclerosis.
CHARLOTTESVILLE, June 29 - The Blue Ridge Chapter of the National Multiple Sclerosis Society is excited to announce that Bike MS: Tour De Vine 2012 has raised more than $270,000 to date and hosted over 400 registered cyclists. The event, sponsored by Stop-In Foods, took place June 9 and 10 at The Park at the University of Virginia.
The top fundraiser was Gail Callaway of Hagerstown, MD with $9,877 raised. The top team award went to Team Grateful Tread of Harrisonburg, VA raising $41,350.90. Team Crutchfield of Charlottesville, VA was recognized as the top corporate team with $16,666 raised.
Fundraising efforts continue through July 12. Monies raised go directly to the Society’s mission to mobilize people and resources to drive research for a cure and to address the challenges of everyone affected by MS. More than 6,000 individuals living with MS in the Blue Ridge Chapter benefit through programs and services from the funds raised at signature events such as Bike MS.
The ride featured one of the oldest and most celebrated Blue Ridge traditions – vineyards and wineries. Cyclists enjoyed routes through the heart of Albemarle County, to beautiful central Virginia vineyards and with scenic views of the foothills of the Blue Ridge Mountains. Tour De Vine is one of 100 rides across the nation hosted and facilitated by the National MS Society in the Premier Fundraising Cycling Series in the Nation.
Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain and between the brain and body. Every hour in the United States, someone is newly diagnosed with the disease. Symptoms range from Numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50 with at least two to three times more women than men being diagnosed with the disease. MS affects more than 400,000 people in the U.S. and over 2.1 million worldwide.
Studies show that early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at nationaMSsociety.org/vab or 1-800-344-4867.